Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 62,485 |
|
|||||
| News | - | ||||||
| Day High | 1.0399 | Low High |
|||||
| Day Low | 0.98 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MiNK Therapeutics Inc | INKT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0048 | 0.47% | 1.0248 | 15:30:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.02 | 0.98 | 1.0399 | 1.02 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 538 | 62,485 | $ 1.01 | $ 63,251 | - | 0.75 - 3.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:31:17 | 1 | $ 1.02 | USD |
MiNK Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 35.21M | 34.52M | - | 0 | -22.46M | -0.65 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MiNK Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INKT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.92 | 1.30 | 0.89 | 1.00 | 1,170,483 | 0.1048 | 11.39% |
| 1 Month | 0.8705 | 1.30 | 0.86 | 0.990637 | 335,309 | 0.1543 | 17.73% |
| 3 Months | 0.9002 | 1.90 | 0.78 | 1.09 | 193,559 | 0.1246 | 13.84% |
| 6 Months | 0.9601 | 1.90 | 0.75 | 1.06 | 118,609 | 0.0647 | 6.74% |
| 1 Year | 1.70 | 3.34 | 0.75 | 1.40 | 100,285 | -0.6752 | -39.72% |
| 3 Years | 12.04 | 22.155 | 0.75 | 2.91 | 120,189 | -11.02 | -91.49% |
| 5 Years | 12.04 | 22.155 | 0.75 | 2.91 | 120,189 | -11.02 | -91.49% |
MiNK Therapeutics Description
| MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses. |
